Results 271 to 280 of about 117,235 (282)

Finerenone in Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine
Jinshi, Zhang, Bin, Zhu, Yueming, Liu
openaire   +4 more sources

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2006
Steven J Jacobsen
exaly  

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

JAMA - Journal of the American Medical Association, 2013
Frank Edelmann, Rolf Wachter, Hans-Dirk Duengen   +2 more
exaly  

Heart Failure with Preserved Ejection Fraction

2009
James Gallagher, Michael Fong
openaire   +1 more source

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

JAMA - Journal of the American Medical Association, 2013
Barry A Borlaug, Douglas L Mann, Anita Deswal   +2 more
exaly  

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Lancet, The
Sanjiv J Shah, Dalane W Kitzman, Subodh Verma   +2 more
exaly  

Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study

New England Journal of Medicine, 2006
R Sacha Bhatia, Jack V Tu, Jiming Fang
exaly  

Heart failure with preserved ejection fraction: everything the clinician needs to know

Lancet, The
Frans H Rutten
exaly  

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

Lancet, The
Dalane W Kitzman, Sanjiv J Shah, Subodh Verma   +2 more
exaly  

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

New England Journal of Medicine
Milton Packer, Venu Menon
exaly